Comment
doi: 10.1245/s10434-011-1809-x.
Epub 2011 Jun 1.
Erlotinib and pancreatic adenocarcinoma: uncertainty and hope
- PMID: 21630121
- DOI: 10.1245/s10434-011-1809-x
Item in Clipboard
Comment
Erlotinib and pancreatic adenocarcinoma: uncertainty and hope
Ann Surg Oncol.
2011 Dec.
No abstract available
Comment on
-
Phase II study of gemcitabine and erlotinib as adjuvant therapy for patients with resected pancreatic cancer.Ann Surg Oncol. 2011 Apr;18(4):1122-9. doi: 10.1245/s10434-010-1401-9. Epub 2010 Nov 23. Ann Surg Oncol. 2011. PMID: 21104328 Clinical Trial.
Similar articles
-
[Changes in chemotherapy for pancreatic adenocarcinoma].Gastroenterol Clin Biol. 2002 Jun-Jul;26(6-7):603-4. Gastroenterol Clin Biol. 2002. PMID: 12193859 French. No abstract available.
-
Keys to personalized care in pancreatic oncology.J Clin Oncol. 2012 Nov 20;30(33):4049-50. doi: 10.1200/JCO.2012.45.1799. Epub 2012 Oct 8. J Clin Oncol. 2012. PMID: 23045599 No abstract available.
-
Perspectives in chemotherapy of pancreatic cancer.Eur J Surg Oncol. 1991 Apr;17(2):153-66. Eur J Surg Oncol. 1991. PMID: 1707835 Review. No abstract available.
-
Therapeutic advances in pancreatic cancer: miles to go before we sleep.J Natl Cancer Inst. 2015 Jan 31;107(2):dju439. doi: 10.1093/jnci/dju439. Print 2015 Feb. J Natl Cancer Inst. 2015. PMID: 25638250 No abstract available.
-
[Therapy of locally advanced pancreatic cancer with FOLFIRINOX].Chirurg. 2016 Aug;87(8):699. doi: 10.1007/s00104-016-0251-9. Chirurg. 2016. PMID: 27418266 Review. German. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
